UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): May 10, 2012 (May 7, 2012)

 

 

Newcastle Investment Corp.

(Exact name of registrant as specified in its charter)

 

 

Maryland

(State or other jurisdiction of incorporation)

 

001-31458   81-0559116

(Commission

File Number)

 

(IRS Employer

Identification No.)

1345 Avenue of the Americas, 46th Floor

New York, New York

  10105
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code (212) 798-6100

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.07 – Submission of Matters to a Vote of Security Holders

At the Annual Meeting of Stockholders held on May 7, 2012, the stockholders of Newcastle Investment Corp. (the “Company”) voted on the matters described below.

1. The Company’s stockholders elected two Class I directors, who comprise all the directors of such class, to serve until the 2015 annual meeting of stockholders or until their successors are elected and duly qualified.

The table below shows the numbers of shares that (i) voted for the election of such directors, (ii) withheld authority to vote for such directors, and (iii) represented broker non-votes with respect to this proposal.

 

Director Nominee

   Votes For      Votes
Withheld
     Broker
Non-Votes*
 

Alan Tyson

     53,389,535         7,083,726         35,723,540   

Stuart McFarland

     53,090,721         7,382,540         35,723,540   

2. The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2012.

The table below shows the numbers of shares that (i) voted for, (ii) voted against and (iii) abstained from voting for or against the ratification of the selection of Ernst & Young LLP.

 

Votes For

   Votes
Against
     Abstentions  
94,948,340      736,056         512,405   

3. The Company’s stockholders approved the 2012 Nonqualified Stock Option and Incentive Award Plan.

The table below shows the numbers of shares that (i) voted for, (ii) voted against, (iii) abstained from voting for or against, and (iv) represented broker non-votes with respect to this proposal.

 

Votes For

   Votes
Against
     Abstentions      Broker
Non-Votes*
 
42,063,940      17,196,731         1,212,590         35,723,540   

 

* Broker non-votes represent shares held by broker nominees for beneficial owners that were not voted with respect to a non-routine proposal because the broker nominee did not receive voting instructions from the beneficial owner and lacked discretionary authority to vote the shares.

If a broker does not receive voting instructions from the beneficial owner, a broker may vote on routine matters but may not vote on non-routine matters.

Broker non-votes are counted for the purpose of determining the presence or absence of a quorum but are not counted for the purpose of determining the number of shares entitled to vote on non-routine matters such as an election of director.

 

2


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

NEWCASTLE INVESTMENT CORP.
(Registrant)

/s/ Brian C. Sigman

Brian C. Sigman
Chief Financial Officer

Date: May 10, 2012

 

3